Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets

Author(s):  Alexander Kenneth S, Kothapalli Madhu R, Dollimor David

Issue:  Jan/Feb 1997 - Hospice Care
View All Articles in Issue

Page(s):  60-63

Note:  Electronic version includes errata or revisions.

Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Page 1
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Page 2
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Page 3
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets Page 4

Download in electronic PDF format for $75

Abstract:  The stability of a 40-µg/mL extemporaneously formulated syrup from commercially available levothyroxine sodium tablets, using sorbitol 70% as the diluting vehicle, was studied. The concentration of levothyroxine sodium in the formulation was 40 µg/mL. The protocol included accelerated stability testing at temperatures of 40°, 50°, 60° and 70°C and a high-performance liquid chromatography assay procedure using testosterone propionate as the internal standard. The data were analyzed using an Arrhenius plot to determine the shelf-life of the formulation. The shelf-life was found to be approximately 15 days at 25°C and 47 days at 5°C.

Related Keywords: Synthroid

Related Categories: GERIATRICS, PEDIATRICS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets
Alexander Kenneth S
, Kothapalli Madhu R, Dollimor David
Jan/Feb 1997
Pg. 60-63

Stability of Lisinopril Syrup (2 mg/mL) Extemporaneously Compounded from Tablets
Rose Deidra J
, Webster Andrew A, English Brett A, McGuire J Michael
Sep/Oct 2000
Pg. 398-399

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Stability of Levothyroxine Sodium Injection in Polypropylene Syringes
Gupta Vishnu D
Nov/Dec 2000
Pg. 482-483

Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules
Fortner Jeff
, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
Sep/Oct 2015
Pg. 414-419

The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions
Svirskis Darren
, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei
Mar/Apr 2018
Pg. 164-171

Stability of Ampicillin Sodium, Nafcillin Sodium, and Oxacillin Sodium in AutoDose Infusion System Bags
Zhang Yanping
, Trissel Lawrence A
May/Jun 2002
Pg. 226-229

Basics of Compounding for Cold Sores or Fever Blisters
Allen Loyd V Jr
May/Jun 2004
Pg. 206-209

Stability of Metronidazole Free-base Oral Suspensions Formulated with United States Pharmacopeia-grade Metronidazole Powder and Commercial Metronidazole Tablets
Jarouche Marian
, Ibrahim Martha, Pearson Jarryd, Low Mitchell, Rowe James
Jan/Feb 2020
Pg. 77-82

Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets
Zaid Abdel Naser
, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa'
Jul/Aug 2012
Pg. 342-346

Stability of Extemporaneously Prepared Sodium Benzoate Oral Suspension
Atkins Julia R
, Lull Melinda E, Decker Andrew S, Hutchinson David J
Jul/Aug 2018
Pg. 326-328

Levothyroxine Sodium 100-mcg Capsules
Allen Loyd V Jr
Nov/Dec 2013
Pg. 505

Levothyroxine Sodium 40-micro-g/mL Oral Liquid
Allen Loyd V Jr
May/Jun 2007
Pg. 247

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets
Cheung Matthew
, Zhao Fang, Dave Vivek S
Jan/Feb 2021
Pg. 82-87

Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures
Nahata Milap C
Sep/Oct 2015
Pg. 428-431

Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets
Liew Kai Bin
, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
May/Jun 2022
Pg. 255-263

Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Sep/Oct 2021
Pg. 431-439

Comparison of Disintegrant-addition Methods on the Compounding of Orodispersible Tablets
Mahesparan Vishnu A/L
, Bin Abd Razak Fashli Syafiq, Ming Long Chiau, Uddin ABM Helal, Sarker Md Zaidul Islam, Bin Liew Kai
Mar/Apr 2020
Pg. 148-155

Formulation Development and Stability Testing of Extemporaneous Suspension Prepared From Dapsone Tablets
Kaila Nitin
, El-Ries Mohamed, Riga A, Alexander Kenneth S, Dollimore D
May/Jun 2003
Pg. 233-239

Return to Top